 | • レポートコード：QYR2104Z3145 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫診断、臨床微生物学、PCR、INAAT、DNAシーケンシング・NGS、DNAマイクロアレイ、その他）、用途別市場規模（病院・臨床検査室、参照検査室、学術・研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染症検査の市場動向 ・企業の競争状況、市場シェア ・感染症検査の種類別市場規模（免疫診断、臨床微生物学、PCR、INAAT、DNAシーケンシング・NGS、DNAマイクロアレイ、その他） ・感染症検査の用途別市場規模（病院・臨床検査室、参照検査室、学術・研究所、その他） ・感染症検査の北米市場規模2016-2027（アメリカ、カナダ） ・感染症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Diagnostics、Abbott、Beckman Coulter Diagnostics、Roche、Siemens Healthcare、Abaxis、Acon Laboratories、Avioq、BD、Bio-Rad Laboratories、Cavidi、Cepheid、Chembio Diagnostic Systems、Clarity Diagnostics、EMD Millipore、Epitope Diagnostic、Gold Standard Diagnostics、Hologic、Immunetics、InBios International、Life Technologies、Maxim Biomedical） ・結論 |
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Market Analysis and Insights: Global Infectious Disease Testing Market
The global Infectious Disease Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Testing market.
Global Infectious Disease Testing Scope and Market Size
Infectious Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Technology
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Segment by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Roche
Siemens Healthcare
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology: 2016 VS 2021 VS 2027
1.2.2 Immunodiagnostics
1.2.3 Clinical Microbiology
1.2.4 PCR
1.2.5 INAAT
1.2.6 DNA Sequencing & NGS
1.2.7 DNA Microarrays
1.2.8 Other
1.3 Market by Application
1.3.1 Global Infectious Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals/Clinical Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic/Research Institutes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Testing Market Perspective (2016-2027)
2.2 Infectious Disease Testing Growth Trends by Regions
2.2.1 Infectious Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Testing Industry Dynamic
2.3.1 Infectious Disease Testing Market Trends
2.3.2 Infectious Disease Testing Market Drivers
2.3.3 Infectious Disease Testing Market Challenges
2.3.4 Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Testing Players by Revenue
3.1.1 Global Top Infectious Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Testing Revenue
3.4 Global Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2020
3.5 Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Testing Breakdown Data by Technology
4.1 Global Infectious Disease Testing Historic Market Size by Technology (2016-2021)
4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027)
5 Infectious Disease Testing Breakdown Data by Application
5.1 Global Infectious Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Disease Testing Market Size (2016-2027)
6.2 North America Infectious Disease Testing Market Size by Technology
6.2.1 North America Infectious Disease Testing Market Size by Technology (2016-2021)
6.2.2 North America Infectious Disease Testing Market Size by Technology (2022-2027)
6.2.3 North America Infectious Disease Testing Market Size by Technology (2016-2027)
6.3 North America Infectious Disease Testing Market Size by Application
6.3.1 North America Infectious Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Testing Market Size by Application (2016-2027)
6.4 North America Infectious Disease Testing Market Size by Country
6.4.1 North America Infectious Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Infectious Disease Testing Market Size (2016-2027)
7.2 Europe Infectious Disease Testing Market Size by Technology
7.2.1 Europe Infectious Disease Testing Market Size by Technology (2016-2021)
7.2.2 Europe Infectious Disease Testing Market Size by Technology (2022-2027)
7.2.3 Europe Infectious Disease Testing Market Size by Technology (2016-2027)
7.3 Europe Infectious Disease Testing Market Size by Application
7.3.1 Europe Infectious Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Testing Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Testing Market Size by Country
7.4.1 Europe Infectious Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Testing Market Size by Technology
8.2.1 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2027)
8.3 Asia-Pacific Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Disease Testing Market Size (2016-2027)
9.2 Latin America Infectious Disease Testing Market Size by Technology
9.2.1 Latin America Infectious Disease Testing Market Size by Technology (2016-2021)
9.2.2 Latin America Infectious Disease Testing Market Size by Technology (2022-2027)
9.2.3 Latin America Infectious Disease Testing Market Size by Technology (2016-2027)
9.3 Latin America Infectious Disease Testing Market Size by Application
9.3.1 Latin America Infectious Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Testing Market Size by Country
9.4.1 Latin America Infectious Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Testing Market Size by Technology
10.2.1 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2027)
10.3 Middle East & Africa Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)
11.1.5 Abbott Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Disease Testing Introduction
11.2.4 Abbott Revenue in Infectious Disease Testing Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Beckman Coulter Diagnostics
11.3.1 Beckman Coulter Diagnostics Company Details
11.3.2 Beckman Coulter Diagnostics Business Overview
11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction
11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)
11.3.5 Beckman Coulter Diagnostics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Infectious Disease Testing Introduction
11.4.4 Roche Revenue in Infectious Disease Testing Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Infectious Disease Testing Introduction
11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 Abaxis
11.6.1 Abaxis Company Details
11.6.2 Abaxis Business Overview
11.6.3 Abaxis Infectious Disease Testing Introduction
11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2016-2021)
11.6.5 Abaxis Recent Development
11.7 Acon Laboratories
11.7.1 Acon Laboratories Company Details
11.7.2 Acon Laboratories Business Overview
11.7.3 Acon Laboratories Infectious Disease Testing Introduction
11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021)
11.7.5 Acon Laboratories Recent Development
11.8 Avioq
11.8.1 Avioq Company Details
11.8.2 Avioq Business Overview
11.8.3 Avioq Infectious Disease Testing Introduction
11.8.4 Avioq Revenue in Infectious Disease Testing Business (2016-2021)
11.8.5 Avioq Recent Development
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Infectious Disease Testing Introduction
11.9.4 BD Revenue in Infectious Disease Testing Business (2016-2021)
11.9.5 BD Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Cavidi
11.11.1 Cavidi Company Details
11.11.2 Cavidi Business Overview
11.11.3 Cavidi Infectious Disease Testing Introduction
11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2016-2021)
11.11.5 Cavidi Recent Development
11.12 Cepheid
11.12.1 Cepheid Company Details
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Infectious Disease Testing Introduction
11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2016-2021)
11.12.5 Cepheid Recent Development
11.13 Chembio Diagnostic Systems
11.13.1 Chembio Diagnostic Systems Company Details
11.13.2 Chembio Diagnostic Systems Business Overview
11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction
11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021)
11.13.5 Chembio Diagnostic Systems Recent Development
11.14 Clarity Diagnostics
11.14.1 Clarity Diagnostics Company Details
11.14.2 Clarity Diagnostics Business Overview
11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction
11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)
11.14.5 Clarity Diagnostics Recent Development
11.15 EMD Millipore
11.15.1 EMD Millipore Company Details
11.15.2 EMD Millipore Business Overview
11.15.3 EMD Millipore Infectious Disease Testing Introduction
11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021)
11.15.5 EMD Millipore Recent Development
11.16 Epitope Diagnostic
11.16.1 Epitope Diagnostic Company Details
11.16.2 Epitope Diagnostic Business Overview
11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction
11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021)
11.16.5 Epitope Diagnostic Recent Development
11.17 Gold Standard Diagnostics
11.17.1 Gold Standard Diagnostics Company Details
11.17.2 Gold Standard Diagnostics Business Overview
11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction
11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)
11.17.5 Gold Standard Diagnostics Recent Development
11.18 Hologic
11.18.1 Hologic Company Details
11.18.2 Hologic Business Overview
11.18.3 Hologic Infectious Disease Testing Introduction
11.18.4 Hologic Revenue in Infectious Disease Testing Business (2016-2021)
11.18.5 Hologic Recent Development
11.18 Immunetics
.1 Immunetics Company Details
.2 Immunetics Business Overview
.3 Immunetics Infectious Disease Testing Introduction
.4 Immunetics Revenue in Infectious Disease Testing Business (2016-2021)
.5 Immunetics Recent Development
11.20 InBios International
11.20.1 InBios International Company Details
11.20.2 InBios International Business Overview
11.20.3 InBios International Infectious Disease Testing Introduction
11.20.4 InBios International Revenue in Infectious Disease Testing Business (2016-2021)
11.20.5 InBios International Recent Development
11.21 Life Technologies
11.21.1 Life Technologies Company Details
11.21.2 Life Technologies Business Overview
11.21.3 Life Technologies Infectious Disease Testing Introduction
11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2016-2021)
11.21.5 Life Technologies Recent Development
11.22 Maxim Biomedical
11.22.1 Maxim Biomedical Company Details
11.22.2 Maxim Biomedical Business Overview
11.22.3 Maxim Biomedical Infectious Disease Testing Introduction
11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021)
11.22.5 Maxim Biomedical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunodiagnostics
Table 3. Key Players of Clinical Microbiology
Table 4. Key Players of PCR
Table 5. Key Players of INAAT
Table 6. Key Players of DNA Sequencing & NGS
Table 7. Key Players of DNA Microarrays
Table 8. Key Players of Other
Table 9. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Infectious Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Infectious Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Infectious Disease Testing Market Share by Regions (2016-2021)
Table 13. Global Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Infectious Disease Testing Market Share by Regions (2022-2027)
Table 15. Infectious Disease Testing Market Trends
Table 16. Infectious Disease Testing Market Drivers
Table 17. Infectious Disease Testing Market Challenges
Table 18. Infectious Disease Testing Market Restraints
Table 19. Global Infectious Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Infectious Disease Testing Market Share by Players (2016-2021)
Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020)
Table 22. Ranking of Global Top Infectious Disease Testing Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Infectious Disease Testing Product Solution and Service
Table 26. Date of Enter into Infectious Disease Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021)
Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027) (US$ Million)
Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027) & (US$ Million)
Table 32. Global Infectious Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Infectious Disease Testing Revenue Market Share by Application (2016-2021)
Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Infectious Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 37. North America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 38. North America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 43. Europe Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 44. Europe Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 49. Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 55. Latin America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 56. Latin America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)
Table 61. Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Diagnostics Company Details
Table 67. Abbott Diagnostics Business Overview
Table 68. Abbott Diagnostics Infectious Disease Testing Product
Table 69. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 70. Abbott Diagnostics Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Infectious Disease Testing Product
Table 74. Abbott Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Beckman Coulter Diagnostics Company Details
Table 77. Beckman Coulter Diagnostics Business Overview
Table 78. Beckman Coulter Diagnostics Infectious Disease Testing Product
Table 79. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 80. Beckman Coulter Diagnostics Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Infectious Disease Testing Product
Table 84. Roche Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Siemens Healthcare Company Details
Table 87. Siemens Healthcare Business Overview
Table 88. Siemens Healthcare Infectious Disease Testing Product
Table 89. Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 90. Siemens Healthcare Recent Development
Table 91. Abaxis Company Details
Table 92. Abaxis Business Overview
Table 93. Abaxis Infectious Disease Testing Product
Table 94. Abaxis Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 95. Abaxis Recent Development
Table 96. Acon Laboratories Company Details
Table 97. Acon Laboratories Business Overview
Table 98. Acon Laboratories Infectious Disease Testing Product
Table 99. Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 100. Acon Laboratories Recent Development
Table 101. Avioq Company Details
Table 102. Avioq Business Overview
Table 103. Avioq Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 104. Avioq Recent Development
Table 105. BD Company Details
Table 106. BD Business Overview
Table 107. BD Infectious Disease Testing Product
Table 108. BD Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 109. BD Recent Development
Table 110. Bio-Rad Laboratories Company Details
Table 111. Bio-Rad Laboratories Business Overview
Table 112. Bio-Rad Laboratories Infectious Disease Testing Product
Table 113. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 114. Bio-Rad Laboratories Recent Development
Table 115. Cavidi Company Details
Table 116. Cavidi Business Overview
Table 117. Cavidi Infectious Disease Testing Product
Table 118. Cavidi Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 119. Cavidi Recent Development
Table 120. Cepheid Company Details
Table 121. Cepheid Business Overview
Table 122. Cepheid Infectious Disease Testing Product
Table 123. Cepheid Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 124. Cepheid Recent Development
Table 125. Chembio Diagnostic Systems Company Details
Table 126. Chembio Diagnostic Systems Business Overview
Table 127. Chembio Diagnostic Systems Infectious Disease Testing Product
Table 128. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 129. Chembio Diagnostic Systems Recent Development
Table 130. Clarity Diagnostics Company Details
Table 131. Clarity Diagnostics Business Overview
Table 132. Clarity Diagnostics Infectious Disease Testing Product
Table 133. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 134. Clarity Diagnostics Recent Development
Table 135. EMD Millipore Company Details
Table 136. EMD Millipore Business Overview
Table 137. EMD Millipore Infectious Disease Testing Product
Table 138. EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 139. EMD Millipore Recent Development
Table 140. Epitope Diagnostic Company Details
Table 141. Epitope Diagnostic Business Overview
Table 142. Epitope Diagnostic Infectious Disease Testing Product
Table 143. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 144. Epitope Diagnostic Recent Development
Table 145. Gold Standard Diagnostics Company Details
Table 146. Gold Standard Diagnostics Business Overview
Table 147. Gold Standard Diagnostics Infectious Disease Testing Product
Table 148. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 149. Gold Standard Diagnostics Recent Development
Table 150. Hologic Company Details
Table 151. Hologic Business Overview
Table 152. Hologic Infectious Disease Testing Product
Table 153. Hologic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 154. Hologic Recent Development
Table 155. Immunetics Company Details
Table 156. Immunetics Business Overview
Table 157. Immunetics Infectious Disease Testing Product
Table 158. Immunetics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 159. Immunetics Recent Development
Table 160. InBios International Company Details
Table 161. InBios International Business Overview
Table 162. InBios International Infectious Disease Testing Product
Table 163. InBios International Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 164. InBios International Recent Development
Table 165. Life Technologies Company Details
Table 166. Life Technologies Business Overview
Table 167. Life Technologies Infectious Disease Testing Product
Table 168. Life Technologies Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 169. Life Technologies Recent Development
Table 170. Maxim Biomedical Company Details
Table 171. Maxim Biomedical Business Overview
Table 172. Maxim Biomedical Infectious Disease Testing Product
Table 173. Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)
Table 174. Maxim Biomedical Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Testing Market Share by Technology: 2020 VS 2027
Figure 2. Immunodiagnostics Features
Figure 3. Clinical Microbiology Features
Figure 4. PCR Features
Figure 5. INAAT Features
Figure 6. DNA Sequencing & NGS Features
Figure 7. DNA Microarrays Features
Figure 8. Other Features
Figure 9. Global Infectious Disease Testing Market Share by Application: 2020 VS 2027
Figure 10. Hospitals/Clinical Laboratories Case Studies
Figure 11. Reference Laboratories Case Studies
Figure 12. Academic/Research Institutes Case Studies
Figure 13. Other Case Studies
Figure 14. Infectious Disease Testing Report Years Considered
Figure 15. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Infectious Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Infectious Disease Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Infectious Disease Testing Market Share by Regions (2022-2027)
Figure 19. Global Infectious Disease Testing Market Share by Players in 2020
Figure 20. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2020
Figure 22. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021)
Figure 23. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027)
Figure 24. North America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Infectious Disease Testing Market Share by Technology (2016-2027)
Figure 26. North America Infectious Disease Testing Market Share by Application (2016-2027)
Figure 27. North America Infectious Disease Testing Market Share by Country (2016-2027)
Figure 28. United States Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Infectious Disease Testing Market Share by Technology (2016-2027)
Figure 32. Europe Infectious Disease Testing Market Share by Application (2016-2027)
Figure 33. Europe Infectious Disease Testing Market Share by Country (2016-2027)
Figure 34. Germany Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Infectious Disease Testing Market Share by Technology (2016-2027)
Figure 42. Asia-Pacific Infectious Disease Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Infectious Disease Testing Market Share by Region (2016-2027)
Figure 44. China Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Infectious Disease Testing Market Share by Technology (2016-2027)
Figure 52. Latin America Infectious Disease Testing Market Share by Application (2016-2027)
Figure 53. Latin America Infectious Disease Testing Market Share by Country (2016-2027)
Figure 54. Mexico Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Infectious Disease Testing Market Share by Technology (2016-2027)
Figure 58. Middle East & Africa Infectious Disease Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Infectious Disease Testing Market Share by Country (2016-2027)
Figure 60. Turkey Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 65. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 67. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 68. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 69. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 70. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 71. BD Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 73. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 74. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 75. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 76. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 77. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 78. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 79. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 80. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 81. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 82. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 83. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 84. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
世界の感染症検査における分子診断市場規模・現状・予測（2021年-2027年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …- 世界の感染症診断検査市場規模・現状・予測（2021年-2027年） In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Biochemical tests used in th…
- 世界の感染症迅速診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Disease Rapid Diagnostic Testing Market The global Infectious Disease Rapid Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の感染症迅速診断検査キット市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Disease Rapid Diagnostic Testing Kits Market The global Infectious Disease Rapid Diagnostic Testing Kits market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
- 世界の微生物学的検査/臨床微生物学市場規模・現状・予測（2021年-2027年） Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. North Am…